103 related articles for article (PubMed ID: 18802996)
41. Obstacles to human hematopoietic stem cell transduction by recombinant adeno-associated virus 2 vectors.
Srivastava A
J Cell Biochem Suppl; 2002; 38():39-45. PubMed ID: 12046848
[TBL] [Abstract][Full Text] [Related]
42. Cystic fibrosis: a look into the future of prenatal screening and therapy.
Nishida K; Smith Z; Rana D; Palmer J; Gallicano GI
Birth Defects Res C Embryo Today; 2015 Mar; 105(1):73-80. PubMed ID: 25820246
[TBL] [Abstract][Full Text] [Related]
43. Taking the good out of the bad: lentiviral-based gene therapy of the hemoglobinopathies.
Stathopulos PB
Biotechnol Adv; 2003 Sep; 21(6):513-26. PubMed ID: 14499152
[TBL] [Abstract][Full Text] [Related]
44. No false start for novel pseudotyped vectors.
Sanders DA
Curr Opin Biotechnol; 2002 Oct; 13(5):437-42. PubMed ID: 12459334
[TBL] [Abstract][Full Text] [Related]
45. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.
Foti S; Haberman RP; Samulski RJ; McCown TJ
Gene Ther; 2007 Nov; 14(21):1534-6. PubMed ID: 17713567
[TBL] [Abstract][Full Text] [Related]
46. Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.
Hernandez-Alcoceba R; Poutou J; Ballesteros-Briones MC; Smerdou C
Immunotherapy; 2016 Feb; 8(2):179-98. PubMed ID: 26786809
[TBL] [Abstract][Full Text] [Related]
47. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
48. Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B.
Harding TC; Koprivnikar KE; Tu GH; Zayek N; Lew S; Subramanian A; Sivakumaran A; Frey D; Ho K; VanRoey MJ; Nichols TC; Bellinger DA; Yendluri S; Waugh J; McArthur J; Veres G; Donahue BA
Gene Ther; 2004 Jan; 11(2):204-13. PubMed ID: 14712305
[TBL] [Abstract][Full Text] [Related]
49. Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection.
Richard E; Robert E; Cario-André M; Ged C; Géronimi F; Gerson SL; de Verneuil H; Moreau-Gaudry F
Gene Ther; 2004 Nov; 11(22):1638-47. PubMed ID: 15284838
[TBL] [Abstract][Full Text] [Related]
50. [Comparison of several viral vectors for gene therapy of corneal endothelial cells].
Beutelspacher SC; Serbecic N; Tan P; McClure MO
Ophthalmologe; 2005 Dec; 102(12):1168-74. PubMed ID: 15886987
[TBL] [Abstract][Full Text] [Related]
51. Mycophenolate mofetil impairs transduction of single-stranded adeno-associated viral vectors.
Montenegro-Miranda PS; ten Bloemendaal L; Kunne C; de Waart DR; Bosma PJ
Hum Gene Ther; 2011 May; 22(5):605-12. PubMed ID: 21222531
[TBL] [Abstract][Full Text] [Related]
52. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
Logan AC; Lutzko C; Kohn DB
Curr Opin Biotechnol; 2002 Oct; 13(5):429-36. PubMed ID: 12459333
[TBL] [Abstract][Full Text] [Related]
53. RNAi therapy: dominant disease gene gets silenced.
Xu Z; Xia XG
Gene Ther; 2005 Aug; 12(15):1159-60. PubMed ID: 15858609
[No Abstract] [Full Text] [Related]
54. Baboon envelope pseudotyped lentiviral vectors: a highly efficient new tool to genetically manipulate T-cell acute lymphoblastic leukaemia-initiating cells.
Costa C; Hypolite G; Bernadin O; Lévy C; Cosset FL; Asnafi V; Macintyre E; Verhoeyen E; Tesio M
Leukemia; 2017 Apr; 31(4):977-980. PubMed ID: 27922597
[No Abstract] [Full Text] [Related]
55. Lentivirus and foamy virus vectors: novel gene therapy tools.
Pandya S; Klimatcheva E; Planelles V
Expert Opin Biol Ther; 2001 Jan; 1(1):17-40. PubMed ID: 11727544
[TBL] [Abstract][Full Text] [Related]
56. Gene therapy progress and prospects: Parkinson's disease.
Burton EA; Glorioso JC; Fink DJ
Gene Ther; 2003 Sep; 10(20):1721-7. PubMed ID: 12939638
[No Abstract] [Full Text] [Related]
57. [Diagnosis and treatment of leukocyte adhesion deficiency].
Chen TX
Zhonghua Er Ke Za Zhi; 2012 Jan; 50(1):62-4. PubMed ID: 22456078
[No Abstract] [Full Text] [Related]
58. Gene therapy of X-linked severe combined immunodeficiency.
Hacein-Bey-Abina S; de Saint Basile G; Cavazzana-Calvo M
Methods Mol Biol; 2003; 215():247-59. PubMed ID: 12512304
[No Abstract] [Full Text] [Related]
59. Gene therapy in ophthalmology: validation on cultured retinal cells and explants from postmortem human eyes.
Fradot M; Busskamp V; Forster V; Cronin T; Léveillard T; Bennett J; Sahel JA; Roska B; Picaud S
Hum Gene Ther; 2011 May; 22(5):587-93. PubMed ID: 21142470
[TBL] [Abstract][Full Text] [Related]
60. In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy.
Wagner JE; Schön C; Becirovic E; Biel M; Michalakis S
Methods Mol Biol; 2019; 1834():383-390. PubMed ID: 30324456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
